Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 8/20 | 0.62 |
| ▸ | CTSB | P07858 | 7/20 | 0.62 |
| ▸ | CTSL | P07711 | 6/20 | 0.62 |
| ▸ | CTSH | P09668 | 3/20 | 0.62 |
| ▸ | CTSD | P07339 | 1/20 | 0.62 |
| ▸ | LIN28A | Q9H9Z2 | 2/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | BCL6 | P41182 | 1/20 | 0.36 |
| ▸ | BCOR | Q6W2J9 | 1/20 | 0.36 |
| ▸ | PYGL | P06737 | 1/20 | 0.36 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL497135 | 0.88 | CAPN1 (0.60) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL3326999 | 0.84 | CAPN1 (0.52) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL497311 | 0.81 | CAPN1 (0.51) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL20094419 | 0.74 | CAPN1 (0.81) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL24185944 | 0.73 | CAPN1 (0.60) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL30668259 | 0.73 | CAPN1 (0.60) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL30668243 | 0.73 | CAPN1 (0.59) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL30668241 | 0.73 | CAPN1 (0.59) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL24186183 | 0.73 | CAPN1 (0.59) | CAPN1CTSBCTSLCTSHCTSD | |
| SCHEMBL22003072 | 0.72 | CAPN1 (1.00) | CAPN1CTSBCTSLCTSHCTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2124948-B1 | COMPOSITIONS FOR TREATING HYPERPROLIFERATIVE VASCULAR DISORDERS AND CANCERS | NC BIT INC (KR) | 2017-07-26 | — | — | EP | disclosed |
| US-20100120849-A1 | Compositions for Treating Hyperproliferative Vascular Disorders and Cancers | BIOBUD CO., LTD (KR) | 2010-05-13 | — | — | US | disclosed |
| EP-2124948-A1 | COMPOSITIONS FOR TREATING HYPERPROLIFERATIVE VASCULAR DISORDERS AND CANCERS | Biobud Co., Ltd. (KR) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008102932-A1 | COMPOSITIONS FOR TREATING HYPERPROLIFERATIVE VASCULAR DISORDERS AND CANCERS | BIOBUD CO., LTD. (KR) | 2008-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120849-A1 | Compositions for Treating Hyperproliferative Vascular Disorders and Cancers | MKI67, MYLK, PCNA | CAPN1 4329/4885CTSB 3153/4885CTSL 4783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.